ストックスクリーナーアプリを入手
4.85
2.02%
-0.10
アフターアワーズ：
4.81
-0.04
-0.82%
Candel Therapeutics Inc (CADL) 最新ニュース
Candel Therapeutics (CADL) Projected to Post Earnings on Thursday - MarketBeat
Candel Therapeutics, Inc. showcases linoserpaturev immunotherapy progress in recurrent glioblastoma case - Traders Union
United StatesGoodwin Guides Candel Therapeutics On $100 Million Public Offering And $100 Millon Royalty Funding Agreement With RTW - Mondaq
CADL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Understanding the Setup: (CADL) and Scalable Risk - Stock Traders Daily
New Candel Therapeutics hire gets 20,000 stock options at $5.25 - Stock Titan
Candel Therapeutics CEO to present progress on immunotherapies at TD Cowen Health Care Conference - Traders Union
CADL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Hedge Fund and Insider Trading News: David Tepper, Steve Cohen, Ray Dalio, Brevan Howard, Millennium Management, Citadel Investment Group, Candel Therapeutics Inc (CADL), Meta Platforms Inc (META), and More - Insider Monkey
Candel Therapeutics Insider Bought Shares Worth $2,999,996, According to a Recent SEC Filing - marketscreener.com
Paul Manning buys Candel Therapeutics (CADL) shares worth $3m - Investing.com
Candel Therapeutics (NASDAQ:CADL) Director Paul Manning Purchases 550,458 Shares - MarketBeat
Paul Manning buys Candel Therapeutics (CADL) shares worth $3m By Investing.com - Investing.com India
Director Paul B. Manning adds 550,458 Candel (NASDAQ: CADL) shares via revocable trust - Stock Titan
Candel Therapeutics, Inc. (CADL) Stock Analysis: Unveiling a 259% Potential Upside in Biotech - DirectorsTalk Interviews
Candel Therapeutics, Inc. unveils science behind CAN-2409 driving durable tumor immune response - Traders Union
Candel Therapeutics CEO to present at TD Cowen health care conference on March 3 - Proactive financial news
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston - Bitget
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston - The Manila Times
Candel Therapeutics CEO to speak at TD Cowen Boston conference - Stock Titan
Candel Therapeutics Announces Equity Offering to Fund CAN-2409 - TipRanks
Candel Therapeutics Prices 18.35M-Share Offering at $5.45, Expects ~$93.5M Net Proceeds - TradingView
Candel Therapeutics (NASDAQ: CADL) prices $100M common stock sale - Stock Titan
CADLCandel Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Candel Therapeutics Faces Strategic Financial Moves Amidst Stock Offering - timothysykes.com
Candel Therapeutics Prices $100M Public Offering - Intellectia AI
Candel Therapeutics Faces Market Reaction Post-Secondary Offering - StocksToTrade
Candel Therapeutics’ Stock Offering Sees Market Reaction - timothysykes.com
Candel Therapeutics Prices $100 Million Share Offering - Intellectia AI
Candel Therapeutics Faces Mixed Sentiments After Secondary Offering Announcement - StocksToTrade
Candel Therapeutics, Inc. (NASDAQ:CADL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Candel Therapeutics files for offering of 18.3 mln shares of common stock - marketscreener.com
Candel Therapeutics Files For Offering Of 18.3 Mln Shares Of Common Stock - TradingView
Should I hold or sell Candel Therapeutics Inc. nowJuly 2025 Action & Risk Controlled Swing Alerts - mfd.ru
Latham & Watkins Advises RTW Investments on US$100 Million Royalty Funding Agreement With Candel Therapeutics - Latham & Watkins LLP
Key facts: Candel Therapeutics secures $100M funding; plans drug launches - TradingView
Small cap wrap: EnWave, Nextech3D.ai, Candel Therapeutics, EDM Resources… - Proactive financial news
Candel Therapeutics Initiates $100M Stock Offering Amid Market Fluctuations - StocksToTrade
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Stock market today: Dow Jones, S&P 500 futures rise ahead of Q4 GDP numbers—Grail, Candel Therapeutics, Copart in focus - MSN
Candel Therapeutics stock falls on $100 million offering pricing By Investing.com - Investing.com Canada
Candel Therapeutics stock falls on $100 million offering pricing - Investing.com
Stock Market Today: Dow Jones, S&P 500 Futures Slip After Weaker-Than-Expected GDP Report—Grail, Candel Therapeutics, Copart In Focus (UPDATED) - Benzinga
Stock Market Today: Dow Jones, S&P 500 Futures Slip After Weaker-Than-Expected GDP Report—Grail, Candel Therapeutics, Copart In Focus (UPDATED) - Benzinga
Candel Therapeutics prices $100M public offering - Proactive financial news
Akamai, Grail, Candel Therapeutics - TradingView
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Is Candel Therapeutics Stock Falling Friday? - Bitget
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead Of Q4 GDP Numbers-Grail, Candel Therapeutics, Copart In Focus - Bitget
Candel Therapeutics Prices $100 Million Public Offering - marketscreener.com
Cancer biotech Candel prices $100M sale to back prostate launch prep, lung trial - Stock Titan
Candel Therapeutics, Inc. (CADL) Stock Analysis: Biotech's Potential 218% Upside Sparks Investor Interest - DirectorsTalk Interviews
Candel Therapeutics prices $100M public offering at $5.45 per share - MSN
The Technical Signals Behind (CADL) That Institutions Follow - Stock Traders Daily
Candel Therapeutics announces pricing of public offering of 18,348,624 shares at $5.45 each - marketscreener.com
Candel Therapeutics Announces Pricing Of Public Offering Of 18,348,624 Shares At $5.45 Each - TradingView
Candel Therapeutics Announces Pricing of Public Offering - GlobeNewswire
Candel Launches $100 Million Public Offering - Intellectia AI
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):